A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm (Q48107130)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

Stephen M. Husbands

6

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

author name string

Sarah F Cordery

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

Alistair Taverner

2

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

Irna E Ridzwan

3

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

M Begoña Delgado-Charro

5

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

Christopher P Bailey

7

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

publication date

14 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

Addiction Biology

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

19

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

4

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

575-586

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

Neurobiological mechanisms of the reinstatement of drug-conditioned place preference.

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in mice

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Opioidergic modulation of cocaine conditioned place preferences

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Naltrexone and buprenorphine combination in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Comparison of in vivo and in vitro parameters of opiate receptor binding in naive and tolerant dependent rodents

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Treatment of cocaine abuse with buprenorphine

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Reward processing by the opioid system in the brain.

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Buprenorphine‐Based Regimens and Methadone for the Medical Management of Opioid Dependence: Selecting the Appropriate Drug for Treatment

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naı̈ve healthy male volunteers under a naltrexone block

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference.

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Antagonist-agonist combinations as therapies for heroin addiction: back to the future?

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Naltrexone-induced aversions: assessment by place conditioning, taste reactivity, and taste avoidance paradigms

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Dissociation of buprenorphine-induced locomotor sensitization and conditioned place preference in rats

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Naltrexone and relapse prevention treatment for cocaine-dependent patients

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerations

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence

1 reference

https://api.crossref.org/works/10.1111/ADB.12020

21 January 2018

Identifiers

10.1111/ADB.12020

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/23240906

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48107130&oldid=2185477465"